Table 1 Serum lipid levels in ApoE KO mice treated with or without metformin.

From: Telomere stabilization by metformin mitigates the progression of atherosclerosis via the AMPK-dependent p-PGC-1α pathway

 

Total Cholesterol (mg/dl)

Triglycerides (mg/dl)

LDL-C (mg/dl)

HDL-C (mg/dl)

ApoE KO

288.9 ± 31.7

69.5 ± 8.2

178.6 ± 16.2

35.6 ± 3.4

ApoE KO + HFD

485.1 ± 43.2

103.9 ± 14.2

304.2 ± 30.4

51.0 ± 2.7

ApoE KO + HFD +Metformin

358.6 ± 12.2

59.4 ± 3.7

235.9 ± 10.9

44.5 ± 1.5

  1. n = 14 in each group. The data were expressed as the means ± SEs.